A phase I trial to evaluate the effect of Gemcabene on QT interval in healthy volunteers.

Next Previous
Trial Profile

A phase I trial to evaluate the effect of Gemcabene on QT interval in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Gemcabene (Primary)
  • Indications Hypercholesterolaemia; Hyperlipoproteinaemias; Hypertension; Hypertriglyceridaemia; Non-alcoholic steatohepatitis; Osteoarthritis
  • Focus Adverse reactions

    • Most Recent Events

    • 20 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top